GENET-news
To stay informed you can subscribe to the GENET-news list.
2008-11-20 | permalink
GM canarypox vaccine gets green light in New Zealand
A live, genetically modified, canarypox virus vaccine has been given the green light to protect horses in New Zealand if there is a outbreak of equine influenza. If used, it will be the first time a genetically modified organism has been released into the environment. The Environmental Risk Management Authority (Erma) has approved an application by the Racing Board and Equine Health Association to use the vaccine under certain conditions.
- The New Zealand Herald, New Zealand: GM canarypox vaccine gets green light
- Horsetalk, New Zealand: Genetically modified horse vaccine wins approval
- TV NZ, New Zealand: Genetically modified horse flu vaccines are given the go ahead
- Environmental Risk Management Authority, New Zealand: ERMA approves GM equine influenza vaccines
Overview
News
2008-11-20 | permalink
GM canarypox vaccine gets green light in New Zealand
A live, genetically modified, canarypox virus vaccine has been given the green light to protect horses in New Zealand if there is a outbreak of equine influenza. If used, it will be the first time a genetically modified organism has been released into the environment. The Environmental Risk Management Authority (Erma) has approved an application by the Racing Board and Equine Health Association to use the vaccine under certain conditions.
- The New Zealand Herald, New Zealand: GM canarypox vaccine gets green light
- Horsetalk, New Zealand: Genetically modified horse vaccine wins approval
- TV NZ, New Zealand: Genetically modified horse flu vaccines are given the go ahead
- Environmental Risk Management Authority, New Zealand: ERMA approves GM equine influenza vaccines
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.